[1]

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, et al. 2024. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 74(3):229−263

doi: 10.3322/caac.21834
[2]

Han B, Zheng R, Zeng H, Wang S, Sun K, et al. 2024. Cancer incidence and mortality in China, 2022. Journal of the National Cancer Center 4(1):47−53

doi: 10.1016/j.jncc.2024.01.006
[3]

Wu Y, He S, Cao M, Teng Y, Li Q, et al. 2024. Comparative analysis of cancer statistics in China and the United States in 2024. Chinese Medical Journal 137(24):3093−3100

doi: 10.1097/cm9.0000000000003442
[4]

Zhou M, Wang H, Zeng X, Yin P, Zhu J, et al. 2019. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 394(10204):1145−1158

doi: 10.1016/S0140-6736(19)30427-1
[5]

Zhang M, Zhong Y, Bao H, Zhao Z, Huang Z, et al. 2021. Breast cancer screening rates among women aged 20 years and above - China, 2015. China CDC Weekly 3(13):267−273

doi: 10.46234/ccdcw2021.078
[6]

Qiu H, Cao S, Xu R. 2021. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Communications 41(10):1037−1048

doi: 10.1002/cac2.12197
[7]

Lu L, Mullins CS, Schafmayer C, Zeißig S, Linnebacher M. 2021. A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Communications 41(11):1137−1151

doi: 10.1002/cac2.12220
[8]

Wang D, Hu X, Xu H, Chen Y, Wang S, et al. 2024. Trend analysis and age-period-cohort effects on morbidity and mortality of liver cancer from 2010 to 2020 in Guangzhou, China. Frontiers in Oncology 14:1387587

doi: 10.3389/fonc.2024.1387587
[9]

Cheng S, Chen M, Cai J, Sun J, Guo R, et al. 2020. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus (2018 edition). Liver Cancer 9(1):28−40

doi: 10.1159/000503685
[10]

World Health Organization (WHO). 2017. Guide to cancer early diagnosis. Geneva: WHO. www.who.int/publications/i/item/9789241511940
[11]

Miao AY. 2021. 我国癌症病人就医延迟现状研究的文献分析[Literature analysis of delay in seeking medical treatment in patients with cancer in China]. 循证护理[Evidence-Based Nursing] 7:382−385 (in Chinese)
[12]

Wu XD, Cai J, Shui M, Deng Y, Tian YJ, et al. 2018. 胃肠道恶性肿瘤家族史结直肠癌患者延诊现状分析[Analysis of health seeking delay in colorectal cancer patients with gastrointestinal malignant tumor family history]. 中华肿瘤防治杂志[Chinese Journal of Cancer Prevention and Treatment] 25:221−225 (in Chinese)

doi: 10.16073/j.cnki.cjcpt.2018.04.001
[13]

Wu XD, Chen CY, Chao HX, Zheng MC, Ding PD, et al. 2017. 结直肠癌患者就诊延误现状及延误时间影响因素分析[Status of Pre-hospital delay and influencing factors of delay time in patients with colorectal cancer]. 中国全科医学[China National General Practice] 20:4109−4114 (in Chinese)
[14]

Rick TJ, Aagard M, Erwin E, Leintz C, Danik E, et al. 2021. Barriers to cancer care in northern Tanzania: patient and health-system predictors for delayed presentation. JCO Global Oncology 7:1500−1508

doi: 10.1200/GO.21.00253
[15]

Gyeltshen T, Teh HS, Loo CE, Hing NYL, Lim WY, et al. 2024. Factors influencing presentation delay among cancer patients: a cross-sectional study in Malaysia. BMC Public Health 24(1):1260

doi: 10.1186/s12889-024-18643-2
[16]

Vatvani AD, Gunawan C, Waren K, Thobias Adiya IDGK, Kurniawan A. 2017. Association between symptom burdens with delayed medical presentation and treatment in Indonesian cancer patients. Annals of Oncology 28:x164

doi: 10.1093/annonc/mdx676.029
[17]

Raihan R. 2016. Hepatitis in Malaysia: past, present, and future. Euroasian Journal of Hepato-Gastroenterology 6:52−55

doi: 10.5005/jp-journals-10018-1167
[18]

Ministry of Health Republic of Indonesia. 2024. Indonesia National Cancer Control Plan 2024−2034. Jakarta: Ministry of Health of the Republic of Indonesia. www.iccp-portal.org/system/files/plans/Rencana_Kanker_Nasional_2024-2034.pdf
[19]

Malik GA, Ansari M, Amer M. 2016. Factors responsible for delay in diagnosis & treatment of colorectal carcinoma. Pakistan Journal of Medical & Health Sciences 7(2):373−377
[20]

Sarrió RG, Benítez Fuentes JD, García Samblás V, Guillot Morales M, Palacios Ozores P, et al. 2026. Impact of social determinants on the development, diagnosis, and treatment of cancer: recommended public health interventions. Clinical & Translational Oncology 28(6):2041−2055

doi: 10.1007/s12094-025-04129-z
[21]

Sharma G, Gupta S, Gupta A, Kalyani VC, Rohilla KK, et al. 2020. Identification of factors influencing delayed presentation of cancer patients. International Journal of Community Medicine and Public Health 7(5):1705

doi: 10.18203/2394-6040.ijcmph20201709
[22]

Rosenstock IM. 1974. Historical origins of the health belief model. Health Education Monographs 2(4):328−335

doi: 10.1177/109019817400200403
[23]

Holden CE, Wheelwright S, Harle A, Wagland R. 2021. The role of health literacy in cancer care: a mixed studies systematic review. PLoS One 16(11):e0259815

doi: 10.1371/journal.pone.0259815